BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18675891)

  • 1. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
    Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
    Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ measurement of solvent-mediated phase transformations during dissolution testing.
    Aaltonen J; Heinänen P; Peltonen L; Kortejärvi H; Tanninen VP; Christiansen L; Hirvonen J; Yliruusi J; Rantanen J
    J Pharm Sci; 2006 Dec; 95(12):2730-7. PubMed ID: 16892206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous UV imaging and raman spectroscopy for the measurement of solvent-mediated phase transformations during dissolution testing.
    Østergaard J; Wu JX; Naelapää K; Boetker JP; Jensen H; Rantanen J
    J Pharm Sci; 2014 Apr; 103(4):1149-56. PubMed ID: 24496995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-Stokes Raman scattering microscopy.
    Windbergs M; Jurna M; Offerhaus HL; Herek JL; Kleinebudde P; Strachan CJ
    Anal Chem; 2009 Mar; 81(6):2085-91. PubMed ID: 19209888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques.
    Greco K; Bergman TL; Bogner R
    Pharm Dev Technol; 2011 Feb; 16(1):75-87. PubMed ID: 20105086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A discriminatory intrinsic dissolution study using UV area imaging analysis to gain additional insights into the dissolution behaviour of active pharmaceutical ingredients.
    Hulse WL; Gray J; Forbes RT
    Int J Pharm; 2012 Sep; 434(1-2):133-9. PubMed ID: 22626886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility and intrinsic dissolution rate of alprazolam crystal modifications.
    Laihanen N; Muttonen E; Laaksonen M
    Pharm Dev Technol; 1996 Dec; 1(4):373-80. PubMed ID: 9552321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug dissolution rate measurements--evaluation of the rotating disc method.
    Kaunisto E; Nilsson B; Axelsson A
    Pharm Dev Technol; 2009; 14(4):400-8. PubMed ID: 19235631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling solid-state transformations occurring in dissolution testing.
    Laaksonen T; Aaltonen J
    Int J Pharm; 2013 Apr; 447(1-2):218-23. PubMed ID: 23506958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms.
    Paaver U; Lust A; Mirza S; Rantanen J; Veski P; Heinämäki J; Kogermann K
    Int J Pharm; 2012 Jul; 431(1-2):111-9. PubMed ID: 22554403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ dissolution analysis using coherent anti-Stokes Raman scattering (CARS) and hyperspectral CARS microscopy.
    Fussell A; Garbacik E; Offerhaus H; Kleinebudde P; Strachan C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1141-7. PubMed ID: 23994672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid.
    Lehto P; Aaltonen J; Tenho M; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
    J Pharm Sci; 2009 Mar; 98(3):985-96. PubMed ID: 18661533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug.
    Greco K; Mcnamara DP; Bogner R
    J Pharm Sci; 2011 Jul; 100(7):2755-68. PubMed ID: 21328581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
    Maswadeh HM; Semreen MH; Abdulhalim AA
    Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface composition and contact angle relationships for differently prepared solid dispersions.
    Dahlberg C; Millqvist-Fureby A; Schuleit M
    Eur J Pharm Biopharm; 2008 Oct; 70(2):478-85. PubMed ID: 18577450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ dissolution testing using potentiometric sensors.
    Peeters K; De Maesschalck R; Bohets H; Vanhoutte K; Nagels L
    Eur J Pharm Sci; 2008 Aug; 34(4-5):243-9. PubMed ID: 18539443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
    De Zordi N; Moneghini M; Kikic I; Grassi M; Del Rio Castillo AE; Solinas D; Bolger MB
    Eur J Pharm Biopharm; 2012 May; 81(1):131-41. PubMed ID: 22266263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.